2.925

6.85% -0.215

Maravai Lifesciences Holdings Inc (MRVI)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt MRVI? Forum Prognose

Schlusskurs vom Vortag:

$3.14

Offen:

$3.14

24-Stunden-Volumen:

1.20M

Relative Volume:

0.83

Marktkapitalisierung:

$423.18M

Einnahmen:

$288.95M

Nettoeinkommen (Verlust:

$-119.03M

KGV:

-3.2482

EPS:

-0.9005

Netto-Cashflow:

$60.67M

1W Leistung:

-12.43%

1M Leistung:

-5.34%

6M Leistung:

+41.30%

1J Leistung:

-60.79%

1-Tages-Spanne:

$2.91

$3.17

1-Wochen-Bereich:

$2.91

$3.40

52-Wochen-Spanne:

$1.665

$8.29

Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile

Firmenname

Maravai Lifesciences Holdings Inc

Sektor

Healthcare (1139)

Branche

Biotechnology (635)

Telefon

(858) 546-0004

Adresse

10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO

Mitarbeiter

560

Twitter

Nächster Verdiensttermin

2025-03-18

Neueste SEC-Einreichungen

MRVI's Discussions on Twitter

Vergleichen Sie MRVI mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
MRVI Maravai Lifesciences Holdings Inc	2.925	454.29M	288.95M	-119.03M	60.67M	-0.9005
VRTX Vertex Pharmaceuticals Inc	426.23	109.11B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	641.92	68.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	432.67	60.25B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	825.18	50.39B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	186.14	40.44B	447.02M	-1.18B	-868.57M	-6.1812

Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-02-26	Herabstufung	Robert W. Baird	Outperform → Neutral
2024-12-19	Eingeleitet	Guggenheim	Neutral
2024-12-05	Herabstufung	Goldman	Neutral → Sell
2024-11-14	Eingeleitet	Wolfe Research	Peer Perform
2024-11-08	Herabstufung	William Blair	Outperform → Mkt Perform
2024-08-28	Eingeleitet	Wells Fargo	Overweight
2024-08-13	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2024-04-10	Eingeleitet	Craig Hallum	Buy
2023-12-12	Hochstufung	BofA Securities	Neutral → Buy
2023-08-08	Herabstufung	KeyBanc Capital Markets	Overweight → Sector Weight
2023-05-23	Herabstufung	Credit Suisse	Outperform → Neutral
2023-05-09	Herabstufung	Goldman	Buy → Neutral
2023-01-05	Herabstufung	UBS	Buy → Neutral
2022-12-14	Eingeleitet	Deutsche Bank	Buy
2022-12-07	Eingeleitet	RBC Capital Mkts	Outperform
2022-11-03	Herabstufung	BofA Securities	Buy → Neutral
2022-08-25	Eingeleitet	Credit Suisse	Outperform
2021-08-05	Fortgesetzt	Credit Suisse	Outperform
2020-12-16	Eingeleitet	KeyBanc Capital Markets	Overweight
2020-12-15	Eingeleitet	BofA Securities	Buy
2020-12-15	Eingeleitet	Credit Suisse	Outperform
2020-12-15	Eingeleitet	Goldman	Buy
2020-12-15	Eingeleitet	Jefferies	Buy
2020-12-15	Eingeleitet	Robert W. Baird	Outperform
2020-12-15	Eingeleitet	Stifel	Buy
2020-12-15	Eingeleitet	William Blair	Outperform
2020-12-14	Eingeleitet	UBS	Buy

Alle ansehen

Maravai Lifesciences Holdings Inc Aktie (MRVI) Neueste Nachrichten

07:45 AM

Is Maravai LifeSciences Holdings Inc. stock a bargain at current levels2025 Winners & Losers & Safe Entry Momentum Tips - newser.com

07:45 AM

05:10 AM

Identifying reversal signals in Maravai LifeSciences Holdings Inc.July 2025 Outlook & Stepwise Trade Signal Implementation - newser.com

05:10 AM

04:13 AM

Will Maravai LifeSciences Holdings Inc. (MAR) stock benefit from infrastructure billJuly 2025 Market Mood & High Yield Equity Trading Tips - newser.com

04:13 AM

01:18 AM

Is Maravai LifeSciences Holdings Inc. stock ready for a breakoutQuarterly Portfolio Review & Long-Term Safe Investment Plans - newser.com

01:18 AM

12:49 PM

Will Maravai LifeSciences Holdings Inc. (MAR) stock enhance shareholder valueGDP Growth & Consistent Profit Trade Alerts - newser.com

12:49 PM

Nov 02, 2025

Why Maravai LifeSciences Holdings Inc. (MAR) stock appeals to dividend investors2025 Bull vs Bear & Stock Portfolio Risk Control - newser.com

Nov 02, 2025

Will Maravai LifeSciences Holdings Inc. stock reach all time highs in 2025 - newser.com

Nov 02, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

Nov 02, 2025

Will Maravai LifeSciences Holdings Inc. (MAR) stock beat growth indexesQuarterly Trade Review & Reliable Breakout Forecasts - newser.com

Nov 02, 2025

Will Maravai LifeSciences Holdings Inc. stock gain from lower inflationWeekly Trade Analysis & Accurate Technical Buy Alerts - newser.com

Nov 02, 2025

Nov 01, 2025